Although 41.5% of the participants in the performed study previously experienced COVID-19-like symptoms, the anti-SARS-CoV-2 IgM and IgG seronegativity reached 59.0% and 34.3% among them, respectively (p < 0.05). Here, CD40LG is linked to COVID-19.